About
Technology
Issues
FAQ
Search
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg. Impact Factor
Discipline Ranks
h
-index
g
-index
★★
Articles
★★★
Articles
Article Citations
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Institutions
›
Bavarian Nordic
›
top-articles
Bavarian Nordic
53
(top 1%)
papers
2.3K
(top 1%)
citations
21
(top 1%)
h
-index
45
(top 1%)
g
-index
61
all documents
2.5K
doc citations
718
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Cutting Edge: Generation of Splenic CD8+ and CD8− Dendritic Cell Equivalents in Fms-Like Tyrosine Kinase 3 Ligand Bone Marrow Cultures
Journal of Immunology
2005
491
2
Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
JAMA - Journal of the American Medical Association
2016
266
3
Human monkeypox – After 40 years, an unintended consequence of smallpox eradication
Vaccine
2020
207
4
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
Journal of Clinical Oncology
2019
174
5
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection
Journal of Clinical Investigation
2008
122
6
First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors
Clinical Cancer Research
2019
116
7
Clinical and immunologic responses to multiple doses of IMVAMUNE® (Modified Vaccinia Ankara) followed by Dryvax® challenge
Vaccine
2007
105
8
Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-α production
Journal of Gene Medicine
2006
99
9
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
Open Forum Infectious Diseases
2015
92
10
Therapeutic Vaccination of HIV-1-Infected Patients on Haart with a Recombinant HIV-1
Nef
-Expressing Mva: Safety, Immunogenicity and Influence on Viral Load during Treatment Interruption
Antiviral Therapy
2005
90
11
PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing
Nature Immunology
2018
88
12
Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells
Gene Therapy
1998
57
13
Influence of Preassay and Sequence Variations on Viral Load Determination by a Multiplex Real-Time Reverse Transcriptase–Polymerase Chain Reaction for Feline Immunodeficiency Virus
Journal of Acquired Immune Deficiency Syndromes (1999)
2001
57
14
Purification of cell culture‐derived modified vaccinia ankara virus by pseudo‐affinity membrane adsorbers and hydrophobic interaction chromatography
Biotechnology and Bioengineering
2010
47
15
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS
Vaccine
2020
47
16
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
Npj Vaccines
2020
45
17
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
Vaccine
2020
40
18
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine
Journal of Infectious Diseases
2021
39
19
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform
Vaccine
2021
36
20
Effect of i.v. acetaminophen on total hip or knee replacement surgery: A case-matched evaluation of a national patient database
American Journal of Health-System Pharmacy
2015
32
21
The Potential of Big Data Research in HealthCare for Medical Doctors’ Learning
Journal of Medical Systems
2021
28
22
Dendritic Cells from Mice Neonatally Vaccinated with Modified Vaccinia Virus Ankara Transfer Resistance against Herpes Simplex Virus Type I to Naive One-Week-Old Mice
Journal of Immunology
2004
22
23
Capturing of cell culture‐derived modified Vaccinia Ankara virus by ion exchange and pseudo‐affinity membrane adsorbers
Biotechnology and Bioengineering
2010
22
24
Stability and suitability for storage and distribution of Ad26.ZEBOV/MVA-BN®-Filo heterologous prime-boost Ebola vaccine
European Journal of Pharmaceutics and Biopharmaceutics
2018
22
25
Peritoneal cancer treatment with CYP2B1 transfected, microencapsulated cells and ifosfamide
Cancer Gene Therapy
2006
20
26
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines
Journal of Infectious Diseases
2023
18
27
Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors
Oncologist
2020
17
28
A major role for TLR8 in the recognition of vaccinia viral DNA by murine pDC?
Proceedings of the National Academy of Sciences of the United States of America
2010
16
29
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques
Frontiers in Immunology
2022
15
30
The Potential of AI in Health Higher Education to Increase the Students’ Learning Outcomes
TEM Journal
2021
11
31
Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses
Journal of Infectious Diseases
2021
10
32
Results of PROSPECT: A randomized phase 3 trial of PROSTVAC-V/F (PRO) in men with asymptomatic or minimally symptomatic metastatic, castration-resistant prostate cancer.
Journal of Clinical Oncology
2018
10
33
HIV-1 Nef co-localizes with the astrocyte-specific cytoskeleton protein GFAP in persistentlynef-expressing human astrocytes
Journal of NeuroVirology
2001
9
34
JMM — Past and Present
Journal of Molecular Medicine
2002
9
35
Exercise Mataika: White Paper on response to a smallpox bioterrorism release in the Pacific
Global Biosecurity
2019
8
36
MVA-BN as monkeypox vaccine for healthy and immunocompromised
International Journal of Infectious Diseases
2020
7
37
Superantigen Expression Is Driven by Both Mouse Mammary Tumor Virus Long Terminal Repeat-Associated Promoters in Transgenic Mice
Journal of Virology
2000
6
38
Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors
Journal of Gene Medicine
2001
6
39
Prospect: A randomized double-blind phase 3 efficacy study of PROSTVAC-VF immunotherapy in men with asymptomatic/minimally symptomatic metastatic castration-resistant prostate cancer.
Journal of Clinical Oncology
2015
5
40
Fast Clearance of the SARS-CoV-2 Virus in a Patient Undergoing Vaccine Immunotherapy for Metastatic Chordoma: A Case Report
Frontiers in Oncology
2020
2
41
Data science strategies leading to the development of data scientists’ skills in organizations
Neural Computing and Applications
2021
2
42
Biopreparedness: Developing vaccines for an eradicated disease
BioSocieties
2014
1
43
Novel applications of MVA to improve outcomes in immunooncology
Annals of Oncology
2019
1
44
P04.02 A novel cancer immunotherapy combines rMVA-CD40L with tumor targeting antibodies
2020
1
45
A trial of CV301 in combination with anti-PD-1 therapy versus anti-PD-1 therapy in subjects with non-small cell lung cancer.
Journal of Clinical Oncology
2018
1
46
Dynamic Role of Technology in Managing Workforce in Service Delivery During COVID-19 Pandemic
2022
1
47
LB1579. A single and a two-dose regimen of MVA-BN elicit similar memory responses to a boost vaccination two years after the initial regimen, indicating potential flexibility for a delayed second dose of MVA-BN in the ongoing monkeypox emergency
Open Forum Infectious Diseases
2022
1
48
Patent rights and the free research
Expert Opinion on Therapeutic Patents
2007
0
49
LB11. A Single Dose of the MVA-BN Smallpox Vaccine Induces an Early Protective Antibody Response Similar to a Traditional Replicating Vaccine and Is Suitable for Emergency Scenarios
Open Forum Infectious Diseases
2019
0
50
A Modified Vaccine against Smallpox
New England Journal of Medicine
2020
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.